Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Investors Weren’t Impressed With Facebook Inc (FB)’s Results

Page 1 of 2

It’s pretty clear that investors were less than impressed with Facebook Inc (NASDAQ:FB)‘s Q4 earnings announced last week. Sure, revenues, earnings, active users, and most everything else grew significantly compared with the prior year, at least on a non-GAAP basis, but concerns obviously linger.

Along with positive growth in several areas, Facebook Inc (NASDAQ:FB) also saw a dramatic increase in costs, with pressure on margins as a result. But the jump in expenses was only part of the reason for Facebook’s share-price drop after announcing results. Slower-than-expected mobile ad revenues, along with Facebook Inc (NASDAQ:FB) CEO Mark Zuckerberg’s plans for spending in 2013, also put a damper on things.

Facebook Inc (NASDAQ:FB)

A quick recap
On a quarter-to-quarter basis, Facebook Inc (NASDAQ:FB)’s change in accounting relating to when revenue is recognized skews comparisons between Q3 and Q4. With two full years of transaction information now available, Facebook began recognizing revenue when a transaction occurs, not when payment is received. So for Q4, that meant four months of revenue, versus three months in prior quarters.

With that said, on a year-over-year basis, Facebook Inc (NASDAQ:FB) made big strides in several areas. Facebook’s gross revenue in 2012 totaled nearly $5.1 billion, a 37% jump from the prior year. Net income on a non-GAAP basis — accounting for some significant one-time expenses, including $1.1 billion in share-based compensation in Q2 2012, and increased R&D costs for the year — was up 6% to $0.53 a share.

Facebook’s closely watched monthly and daily active user totals also improved, to 1.06 billion and 618 million, respectively. Even more impressive is Facebook’s successful shift to mobile computing. As Zuckerberg put it, “In 2012, we connected over a billion people and became a mobile company.” And it did. Of Facebook’s 1 billion monthly active users, 680 million of them are mobile.

The continued growth in Facebook users is good to see, but transitioning all that activity to revenues is where the rubber meets the road. And for some analysts, the $306 million in Q4 mobile ad revenues — representing 23% of all ad sales for the quarter — was disappointing. Apparently, $350 million of mobile ad revenues was expected for the quarter.

For the year, capital expenditures jumped a whopping $500 million from 2011, and according to guidance from Zuckerberg and team, Facebook Inc (NASDAQ:FB) is expecting expenses to jump by 50% this year, well above most analyst expectations. That, along with the “disappointing” mobile ad revenues, is being cited as the reasons for Facebook’s share-price decline.

Now what?
The market is a fickle place, and Facebook’s drop in stock price since announcing Q4 and 2012 annual results demonstrates it. Need proof? Look no further than, Inc. (NASDAQ:AMZN) . Though the market reacted negatively to its earnings report last week, didn’t get punished the way Facebook has. Why? Because investors recognize that’s bottom line is affected by its commitment to building distribution centers, which, according to CEO Jeff Bezos, will help lower costs and improve margins. Makes sense, and investors have been fairly patient while Bezos does his thing.

Facebook hasn’t been afforded the same courtesy as, which is both good and bad for investors. Bad, because current Facebook shareholders are being stung by share-price pressure. Good, because Facebook, particularly with a price below $29 a share, offers mid-term investors significant growth opportunity. Even one of the analysts who was “disappointed” with mobile ad revenues, has an “overweight” rating on Facebook, and a target price of $38.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!